Define the product
Patients should know exactly what material or procedure is being proposed.
HAIR • REGENERATIVE MEDICINE • SAFETY FIRST
A term used widely in marketing but one that requires precise clarification about what product or procedure is actually being offered.
ABOUT THE TREATMENT
Products promoted as stem-cell hair therapy vary enormously. Some are not true stem-cell treatments at all, while human cell or tissue products may be subject to strict regulation. Lumera Derm does not frame stem-cell therapy as an established cure for hair loss.
Your concern, relevant history and treatment goals are reviewed before suitability is discussed.
The treatment pathway is adapted to your assessment, priorities and realistic goals rather than a fixed protocol.
Technique, intensity and treatment details are selected conservatively according to the service and your individual needs.
Aftercare and follow-up are used to assess response, support recovery and decide whether further treatment is appropriate.
TREATMENT FOCUS
Treatment planning focuses on the factors most relevant to this service, your diagnosis or concern, and safe, realistic outcomes.
Patients should know exactly what material or procedure is being proposed.
A newer option should be compared with treatments that have stronger clinical support.
Use depends on applicable law, product status and appropriate clinical governance.
Claims, product source, processing and regulatory status require careful review before treatment is discussed.
IN MORE DETAIL
Any regenerative option should be considered only after diagnosis, review of established alternatives, and verification of the exact product, evidence and regulatory status.
At Lumera Derm, treatment choice follows assessment. The aim is to match the option to the concern, skin or scalp condition, medical history and realistic goals rather than treating a service name as a one-size-fits-all solution.
YOUR VISIT
Each service follows the same principle: assess first, explain options clearly, then treat only when appropriate.
Discuss the concern, goals, relevant history and any previous treatment.
Confirm suitability, risks, alternatives and whether another pathway would be more appropriate.
Agree on a conservative, personalised plan with realistic expectations.
Follow-up is used to assess response and decide whether any further treatment is worthwhile.
SAFETY & SUITABILITY
Unapproved stem-cell products have been associated with serious safety concerns. A treatment should not proceed simply because it is marketed as “regenerative”.
FREQUENTLY ASKED
Clear answers to common questions before you book.
BOOK A CONSULTATION
Ask questions, understand suitability and decide on the next step without unnecessary forms.